About Amphastar P
Amphastar Pharmaceuticals (NASDAQ:AMPH) is a diversified specialty pharmaceutical company focused on developing, manufacturing, and marketing generic and proprietary injectable, inhalation, and intranasal products. It also develops and manufactures products and product candidates within biologics, insulin, and vaccine markets. With a commitment to innovation and quality, Amphastar aims to enhance patient care by providing affordable and effective pharmaceutical solutions. Its projects span a variety of therapeutic areas, with an ongoing effort to expand its portfolio through robust research and development activities. The company strives to meet the evolving needs of the healthcare sector, aiming for excellence in all facets of its operation, from product development to manufacturing and compliance.
Snapshot
Operations
Produtos e/ou serviços de Amphastar P
- Generic nasal spray products offering affordable relief for allergies and nasal congestion, emphasizing patient accessibility.
- Critical care products including injectable and inhalation drugs for emergency and intensive care use, focusing on life-saving therapies.
- Insulin Active Pharmaceutical Ingredients (API) for diabetes management, demonstrating commitment to addressing chronic health conditions.
- Intranasal Naloxone spray for opioid overdose, a key component in the fight against the opioid crisis, highlighting social responsibility.
- Veterinary medicine formulations designed to enhance the health and wellbeing of animals, showcasing diversification into animal health.
- Contract manufacturing services, providing specialized production capabilities for a broad range of pharmaceutical and biotechnological applications.
equipe executiva do Amphastar P
- Dr. Ziping Luo Ph.D.Chairman of the Board, Chief Scientist & COO
- Dr. Yongfeng Zhang Ph.D.Co-Founder, President, CEO, Chief Scientific Officer & Director
- Mr. William J. Peters M.B.A.CFO, Executive VP of Finance, Treasurer & Director
- Mr. Jacob Liawatidewi M.B.A.Executive VP of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director
- Mr. Rong Zhou M.S.Senior EVP of Production & EVP of Scientific Affairs
- Mr. Dan Dischner M.B.A.Senior Vice President of Human Resources & Corporate Communication
- Tony Marrs M.B.A., M.P.H., M.S.Executive VP of Regulatory Affairs & Clinical Operations